New Jersey § 26:2L-3 Definitions

New Jersey Statutes

§ 26:2L-3 — Definitions

New Jersey·Title 26 HEALTH AND VITAL STATISTICS

As used in this act: a. "Board" means the Therapeutic Research Qualification Review Board established in section 5 of this act.

b."Commissioner" means the State Commissioner of Health.

c."Schedule I controlled dangerous substance" means a controlled dangerous substance having a high addiction liability; no accepted medical use in the United States; and listed in New Jersey Administrative Code 8:65-10.1.

d."Drugs" means drugs as defined in section 2 of P.L.1970, c. 226 (C. 24:21-2).

e."Practitioner" means a physician licensed to prescribe and administer drugs which are subject to the "New Jersey Controlled Dangerous Substances Act" (P.L.1970, c. 226).

f."Program" means the controlled dangerous substances therapeutic research program established in this act. L.1981, c. 72, s. 3, eff. Ma

Free access — add to your briefcase to read the full text and ask questions with AI

As used in this act: a. "Board" means the Therapeutic Research Qualification Review Board established in section 5 of this act. b. "Commissioner" means the State Commissioner of Health. c. "Schedule I controlled dangerous substance" means a controlled dangerous substance having a high addiction liability; no accepted medical use in the United States; and listed in New Jersey Administrative Code 8:65-10.1. d. "Drugs" means drugs as defined in section 2 of P.L.1970, c. 226 (C. 24:21-2). e. "Practitioner" means a physician licensed to prescribe and administer drugs which are subject to the "New Jersey Controlled Dangerous Substances Act" (P.L.1970, c. 226). f. "Program" means the controlled dangerous substances therapeutic research program established in this act. L.1981, c. 72, s. 3, eff. March 23, 1981.

New Jersey § 26:2L-3 (Definitions) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.